AcuityMD Secures $80M to Enhance AI Capabilities in MedTech

AcuityMD Raises $80M to Boost AI in MedTech AcuityMD has successfully closed an $80 million Series C funding round, elevating the company’s valuation to nearly $1 billion. The round, led by StepStone Group with support from Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management, is set to significantly enhance AcuityMD’s AI-driven platform. This funding aims to accelerate technological advancements and foster the widespread adoption of medical devices within the industry.

AcuityMD serves as a critical resource for 16 of the top 20 MedTech companies, offering them access to a proprietary ontology that merges various data sources like claims databases, FDA filings, and market trends. By integrating this ontology with their clients’ internal data, AcuityMD provides a holistic and continuously updated view of the healthcare market. This unique capability empowers medical technology companies to adapt swiftly to industry shifts, such as regulatory changes and hospital consolidations, while capturing increased market share.

The introduction of AcuityAI, currently in open beta, marks a significant step forward. This AI is built upon AcuityMD’s extensive data framework and is designed to offer precision insights tailored to the needs of individual sales reps, facilitating smarter and faster commercial execution. With new funding in hand, AcuityMD is poised for rapid growth and innovation in the MedTech sector, reinforcing its commitment to providing actionable insights and enabling more effective market strategies for its clients.

For the latest updates and in-depth insights into the world of Medical Devices, including breakthrough treatments, industry trends, and regulatory news, contact Albert Baines today!